Posted On: 06/25/2013 9:46:25 PM
Post# of 2145
Here are some good recent deletions
1) "Except the part about the screaming which never happened. So why are you saying it did?"
2)How many major companies need to come Elite or use Elite's tech to satisfy your answer? I just supplied about 6 of them. Obviously they came to 25 million dollar market company because they were skilled and unique or they would just do these things in house.
Maybe if we focus on products, it would be easier?
Oxycontin
Opana
Hydromorphone
Morphine
Which of these do you think Elite is working on for abuse deterrent BE trials?
They already make Hydromorphone. We know they can make Oxy since they already passed Ph1and2.
Actavis gave them the Naltrexone to make all the abuse deterrent formulation and requested they make a 505B2 NDA for them. Obviously Actavis needs Elite to make this formulation. Why else would the third largest drug company in the world come to Elite to develop a drug for them?
3)
I am very excited about the future.
1) "Except the part about the screaming which never happened. So why are you saying it did?"
2)How many major companies need to come Elite or use Elite's tech to satisfy your answer? I just supplied about 6 of them. Obviously they came to 25 million dollar market company because they were skilled and unique or they would just do these things in house.
Maybe if we focus on products, it would be easier?
Oxycontin
Opana
Hydromorphone
Morphine
Which of these do you think Elite is working on for abuse deterrent BE trials?
They already make Hydromorphone. We know they can make Oxy since they already passed Ph1and2.
Actavis gave them the Naltrexone to make all the abuse deterrent formulation and requested they make a 505B2 NDA for them. Obviously Actavis needs Elite to make this formulation. Why else would the third largest drug company in the world come to Elite to develop a drug for them?
3)
Quote:
As a long term investor myself
I am very excited about the future.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)